NFKB1 and Miyoshi myopathy: The next step for studying or targeting B cell differentiation in health and disease is combining the detection of the NF-κB and p-STAT signaling pathways activated by TFH signals with MM analysis, to elucidate the crosstalk between BCR, CD40 and cytokine receptors.